AU2013904239A0 - Pharmaceutical combinations for the treatment of cancer - Google Patents
Pharmaceutical combinations for the treatment of cancerInfo
- Publication number
- AU2013904239A0 AU2013904239A0 AU2013904239A AU2013904239A AU2013904239A0 AU 2013904239 A0 AU2013904239 A0 AU 2013904239A0 AU 2013904239 A AU2013904239 A AU 2013904239A AU 2013904239 A AU2013904239 A AU 2013904239A AU 2013904239 A0 AU2013904239 A0 AU 2013904239A0
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- treatment
- pharmaceutical combinations
- pharmaceutical
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 201000011510 cancer Diseases 0.000 title 1
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2014344789A AU2014344789B2 (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
PL14859220.7T PL3062790T3 (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
JP2016524588A JP2016535014A (en) | 2013-11-01 | 2014-10-31 | Medicinal combination for the treatment of cancer |
CN201480052310.6A CN105792823B (en) | 2013-11-01 | 2014-10-31 | The pharmaceutical composition for treating malignant tumour |
US15/021,217 US9833431B2 (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
EP14859220.7A EP3062790B1 (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
NZ716765A NZ716765A (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
PCT/AU2014/001017 WO2015061832A1 (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
KR1020167008078A KR102271848B1 (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
CA2922575A CA2922575C (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
ES14859220T ES2940890T3 (en) | 2013-11-01 | 2014-10-31 | Pharmaceutical combinations for the treatment of cancer |
HK16110698.6A HK1222548A1 (en) | 2013-11-01 | 2016-09-08 | Pharmaceutical combinations for the treatment of cancer |
JP2019044801A JP6666494B2 (en) | 2013-11-01 | 2019-03-12 | Pharmaceutical combinations for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2013904239A0 true AU2013904239A0 (en) | 2013-11-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3027192A4 (en) | Methods for the treatment of solid tumors | |
EP3030323A4 (en) | Kdm1a inhibitors for the treatment of disease | |
EP2964028A4 (en) | Compounds for treatment of cancer | |
EP3076977A4 (en) | Combination therapy for treating cancer | |
EP3033079A4 (en) | Methods for the treatment of her2 amplified cancer | |
SI3033086T1 (en) | Combination therapy for the treatment of cancer | |
EP3038647A4 (en) | Combination therapy for the treatment of glioblastoma | |
EP3148532A4 (en) | Pharmaceutical combination for the treatment of cancer | |
EP3389645A4 (en) | Combinations for the treatment of cancer | |
EP3436002A4 (en) | Pharmaceutical combinations for the treatment of cancer | |
EP2994148B8 (en) | Cancer therapy | |
PT3089749T (en) | Combined preparations for the treatment of cancer | |
HK1222548A1 (en) | Pharmaceutical combinations for the treatment of cancer | |
EP3004396A4 (en) | Methods and compositions for the treatment of cancer | |
EP3132802A4 (en) | Therapeutic agent for solid cancer | |
EP3007756A4 (en) | Catheter-assisted tumor treatment | |
EP3008212A4 (en) | Methods of treatment of cancer | |
EP2994155A4 (en) | Targeting the egfr-sglt1 interaction for cancer therapy | |
HK1219737A1 (en) | Novel compounds for the treatment of cancer | |
EP3044593A4 (en) | Cancer therapy | |
EP3003489A4 (en) | Cytotoxic agents for the treatment of cancer | |
EP3057593A4 (en) | Treatment for pancreatic cancer | |
HK1223547A1 (en) | Methods for the treatment of cancer | |
EP3046556A4 (en) | Combination drug therapy | |
EP3089745A4 (en) | Compounds, compositions, and methods for the treatment of cancers |